- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01199666
Text Message Reminder-Recalls For Early Childhood Vaccination
July 24, 2014 updated by: Melissa Stockwell, MD, MPH, Columbia University
Text 4 Health-Kids: Text Message Reminder-Recalls For Early Childhood Vaccination
Although the investigators have reached the Healthy People 2010 goal of 80% coverage among U.S. children 19-35 months of age for the primary immunization series, 20% of children still remain underimmunized.
In addition, pockets of low immunization coverage and outbreaks of vaccine preventable disease persist.
Immunization reminder-recalls have been shown to be successful, but have been limited by the ability to identify and reach large target populations in a real-time, automated fashion.
Reminder-recalls via text message may offer an innovative opportunity to improve vaccination coverage.
Currently, 91% of Americans own a cell phone.
Prior research by our team suggests that text messages reminder recalls may be an effective tool to remind parents about their children's vaccines.
In this study, the investigators will demonstrate the effectiveness of tailored text message appointment and immunization reminders linked to a well-established and functional immunization registry to increase coverage rates and timeliness of the sentinel vaccines of MMR and HepA.
The investigators will target parents of young children from an underserved population that is primarily Latino, with low socioeconomic status.
Study Overview
Study Type
Interventional
Enrollment (Actual)
2586
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- Columbia University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
9 months to 50 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Parents of child >9 months to 25 months
- Child with at least one visit to one of the participating clinical sites in the previous 12 months
- Parental cell phone number recorded in the registration system
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Text message reminders
|
text message appointment and immunization reminders
|
|
ACTIVE_COMPARATOR: standard of care for MMR, letter reminder for Hep A
MMR: automated phone call appointment reminder Hep A: recall letter, automated phone call appointment reminder
|
text message appointment and immunization reminders
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Receipt of MMR1
Time Frame: by 13 and 16 months of age
|
by 13 and 16 months of age
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Timeliness of HepA vaccination post-recall
Time Frame: 4,12, 24 weeks
|
4,12, 24 weeks
|
|
Attendance at appointments
Time Frame: after appointment
|
after appointment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Annika Hofstetter, MD PhD MPH, Columbia University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2011
Primary Completion (ACTUAL)
July 1, 2013
Study Completion (ACTUAL)
July 1, 2013
Study Registration Dates
First Submitted
September 9, 2010
First Submitted That Met QC Criteria
September 10, 2010
First Posted (ESTIMATE)
September 13, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
July 25, 2014
Last Update Submitted That Met QC Criteria
July 24, 2014
Last Verified
July 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- AAAF4263
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaccination
-
University of Massachusetts, WorcesterRecruiting
-
University of TorontoWholehealth Pharmacy PartnersNot yet recruitingVaccination | Vaccination Reaction | Vaccination Pain | Vaccination PharmacyCanada
-
University of IowaNational Institute on Aging (NIA)CompletedVaccination | Vaccination Hesitancy | Vaccination Promotion | Psychological AspectsUnited States
-
University of Roma La SapienzaCompletedVaccination Failure | Vaccination Adverse Events | Specific Antibody ResponseItaly
-
Xiamen UniversityXiamen Center for Disease Control and PreventionNot yet recruitingHPV Vaccination Rates | HPV Vaccine Awareness | HPV Vaccination Intention
-
National Cancer Institute (NCI)CompletedHPV16 Anitbody Levels Post Vaccination | HPV18 Antibody Levels Post VaccinationUganda
-
University of PennsylvaniaCompletedVaccine Refusal | Vaccination Hesitancy | Human Papillomavirus VaccinationUnited States
-
Université de Reims Champagne-ArdenneRecruiting
-
University of EssexUniversity of Southern California; Kingston University; Department of Health...Completed
-
China National Biotec Group Company LimitedPeking University; Beijing Institute of Biological Products Co Ltd.; Sichuan... and other collaboratorsCompleted
Clinical Trials on Text message
-
University of California, San FranciscoUniversity of WashingtonCompleted
-
University of WashingtonUniversity of Illinois at Chicago; Kenya Medical Research InstituteCompletedHIV Infections | Acquired Immunodeficiency Syndrome | Circumcision, Male | Patient Compliance | Cellular PhoneKenya
-
Texas Tech University Health Sciences CenterTexas Tech UniversityCompletedBreast Cancer FemaleUnited States
-
University of WashingtonUniversity of California, San Francisco; Kenya Medical Research InstituteCompletedHIV Infections | Acquired Immunodeficiency SyndromeKenya
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Recruiting
-
Emory UniversityNational Cancer Institute (NCI)CompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Columbia UniversityPfizerCompletedVaccinationUnited States
-
Wake Forest University Health SciencesCompleted
-
New York City Health and Hospitals CorporationWithdrawn
-
VA Office of Research and DevelopmentCompletedChronic Disease PreventionUnited States